Carolyn Paisley-Dew, President, Australia

Carolyn joined the ISMRD Board following the death of her son in September 2006 at the age of 10. Matthew had Fucosidosis. Carolyn and her husband Chris live in Canberra, the capital of Australia. Carolyn is retired. She holds an Honours degree in French, with sub-majors in Mathematics and Psychology from the University of Western Australia, and a Graduate Diploma in Management from Monash University, Victoria, Australia.

Carolyn’s dream is to see newborn screening and treatments for all the glycoproteinoses.

Carolyn is co-author of “International online survey of Fucosidosis: key symptoms and the family experience”, presented at WORLDSymposium 2023.

Danielle Forsman, Treasurer, USA

Danielle and her husband Jeff are parents of Sarah, who was born with Alpha-Mannosidosis in 1999 and received a bone marrow transplant in 2003. Sarah currently serves as a board member of ISMRD and is an advocate for the Alpha-Mannosidosis community.

Danielle is a licensed Financial Advisor and is Managing Partner of a financial investment firm that also helps families with special needs planning. She holds a BS in Finance and is currently in a graduate program for her Certified Financial Planner designation.

Danielle’s first experience with ISMRD in 2003 was when Sarah was finally diagnosed at 3 ½ years old and at that meeting with 6 Geneticists, they had given Danielle and Jeff a torn piece of paper with the handwritten website of www.ISMRD.org with the instruction to see what they could find out! A week later they were welcomed down to Baltimore, Maryland for the fine timing of ISMRD’s board meeting being held. They got to “find out more” from those dedicated parents that created this organization which was a life changing experience because ten months later Sarah received a successful bone marrow transplant.

This has come full circle for the Forsman’s, seeing their own daughter born with a rare disease, cope with and overcome the many challenges that this disease brings. Danielle wishes to carry the torch forward by being a part of what the future holds in medical breakthroughs, earlier diagnoses and supporting ISMRD’s community of families.

Sarah Forsman, Communications Officer, USA

Sarah was born with Alpha Mannosidosis and diagnosed at 3.5 years old. She received a bone marrow transplant, a year later in October of 2003. Having since learned more about this rare disease, Sarah wants to help this community of people affected in the same way they helped her parents years ago.

She is in college working towards a Bachelors degree in Marketing with a minor in Psychology. She has found a love for the brain and how magnificent life truly is. In her free time, Sarah enjoys reading, writing blogs about her story, cooking, and hanging with her friends.

Darko Jamnik, Board Member, Slovenia

Darko lives in Ljubljana, the capital of Slovenia, with his wife Mojca and two children: Žiga (born 2007), affected by MLIII, and Daša (born 2010), who is unaffected.

Since leaving his job at Slovenian railways in 1999, Darko has worked at different positions in an IT department at one of Slovenia’s financial institutions.

Darko was impressed with the people he met at the last two ISMRD conferences in Rome, Italy and Atlanta, Georgia. He decided to accept the invitation to become a board member because he considered it a privilege to participate in ISMRD work with the people he had met. He intends to do his best to help ISMRD achieve its goals.

Hussain Peeran, Board Member, USA

Hussain and his wife Syeda became aware of Sialidosis and other lysosomal storage conditions when one of their children was diagnosed as a Sialidosis Type 1 patient.  Karima, at age 8, during a normal visit to get her eyes checked for glasses, was found to have cherry red spots.

Going through the medical system in the US and not finding the appropriate support levels for a cure for this condition propelled Hussain to find other doctors that could help in bringing out a cure. He is active with other families throughout the world to see what else can be done to reduce the impact of Sialidosis and eventually lead to a cure

With a degree in Engineering and a professional background in Management of large Operations and Customer Care teams across a global footprint, he is ideally suited to work with patients and medical companies who are looking to find solutions to treat and cure rare conditions affecting so many families.

Lama Khalil-Qashou, Board Member, Saudi Arabia

Lama is mother of 3 boys, the youngest being Rayan who is affected with Fucosidosis. They live in Saudi Arabia, originally from Jordan.
Lama holds a university degree in civil engineering. She left work to be a stay-at-home mom. Being surrounded with medical people in her family has helped her to diagnose her son with this rare disease. She aims to help other families, and guide them to the right path of a diagnosis. In the Middle East there is little information about Fucosidosis and related diseases, because it is hard to get a test for diagnosis of the rare diseases.

Laurel Gregier, Board Member, USA

Laurel lives in Montana with her husband and two sons. Her oldest son was diagnosed with Beta Mannosidosis in 2014 at the age of 4 and received an experimental bone marrow transplant shortly after his diagnosis.

Laurel is a mental health counselor. She holds a BS in Human Development and Family Studies from Colorado State University and a MS in Clinical Rehabilitation and Mental Health Counseling from Montana State University Billings. She is active in disability advocacy and hopes to raise awareness for ultra-orphan diseases, especially Beta Mannosidosis.

Patricia Gribel, Board Member, Brazil

Patricia is an emergency nurse and has 4 children. Clara (21 years old), Annie (almost 14 years old), J.A. (10 years old) and Aaron (5 years old). Annie has Type 1 Sialidosis and Aaron is autistic.

They are a happy family and live on a farm in Brazil. Her husband Vladimir is her partner in everything, they form a team and support each other in every goal, challenge or event that life brings to them.

Patricia is willing to help in any way to improve the quality of life of families with children with rare diseases and is very happy to be part of the ISMRD team.

Tareq Qashou, Board Member, Saudi Arabia

Tareq is an Anesthesia consultant doctor. He lives and works in Saudi Arabia with his wife, Lama, and their three sons. The youngest, Rayan, is affected with Fucosidosis.

Tareq has wide knowledge and experience in the medical field, and has made many critical decisions on Rayan’s journey to help Rayan have a normal lifestyle. His target is to assist other families with metabolic disease children, and support research in this field.

Cagdas Canbolat, Board Member, England

Cagdas lives in London with his wife, Cinar, and daughter, Clara, who has Galactosialidosis. He graduated in Mathematics and Economics at the London School of Economics in 2006, and is currently a chartered accountant working in local government in London as a director of finance.

Cagdas has been very active in his community in Cambridge and London carrying out various voluntary work, in particular supporting young people from deprived backgrounds and fighting for justice for people from all backgrounds wherever they are in the world.

He has currently paused that part of his voluntary work while he focusses on supporting Clara. He is determined to support and find a cure for this disorder. He is forming links worldwide, has established important contacts, and collated vital materials which will all help bring information related to Galactosialidosis to one place and provide a sound base for anyone willing to invest in introducing a clinical trial. A breakthrough in this is very close, needing the right investment and contributions from metabolic doctors to pharmaceutical companies.

Cagdas has joined the Board of the ISMRD to advocate for those with Glycoprotein Storage Diseases and help the organization raise more awareness in relation to Galactosialidosis. He will continue his journey with ISMRD in finding cures for the glycoprotein storage disorders and helping children to live a life free from these diseases.

Abby Melone, Board Member, USA
Abby is the mother of Layla (born 2019) who was diagnosed with Alpha-Mannosidosis in early 2023. Later that year her family and she returned home to Miami, Florida after successfully completing Layla’s bone marrow transplant in Minneapolis, Minnesota. 
 
When she is not taking care of Layla’s bone marrow transplant aftercare, she runs the publishing company she founded in 2013 which produces annual business reviews, digital content and high level business summits on a variety of US markets.
 
Abby is proud to join ISMRD in hopes to help other parents find the right resources and information in what can be a terribly confusing and nerve racking time.
Mark Stark, Board Emeritus, USA

Mark Stark is the Principal at Stark Tech Consulting, a consulting firm specializing in high-tech product development and market launch.

Mark is also the father of five children. The youngest, Robert, has Alpha-Mannosidosis, and has received two bone marrow transplants. The most recent was in April of 2002 and is, to date, successfully engrafted. Mark’s experience with non-profit organizations comes mostly from his wife, Kathleen King. She is currently Executive Director of the Healthier Kids Foundation of Santa Clara. The mission of Healthier Kids Foundation is to ensure access to and advocacy for health care services for all children through family-centered and innovative approaches, and she is a board member of a number of California based non-profits.

Mark stepped down as a board member at the end of 2022. He has been with ISMRD for twenty years, holding different positions at ISMRD Board including the positions of President and Treasurer. Mark has worked very hard for our nine diseases. He has shown enormous dedication and commitment to our cause, helping to guide the Board with his extensive knowledge and expertise.

John Forman, Board Emeritus, New Zealand

John became a board member of ISMRD in 1999, very soon after it was incorporated as a non-profit. He has held roles as Vice-President and President over the years, and assisted with research and fundraising efforts. His connection with ISMRD stems from his twins, Timothy and Hollie, being born with Alpha-Mannosidosis in 1974. Finding other families in the 1990s was a game changer for him and his wife Judith in understanding what was happening, and improving their care. This experience motivated John to help improve the knowledge available to new families and help promote research efforts.

In addition to his ISMRD connections, John set up and led Lysosomal Diseases NZ from 1999 and the NZ Organisation for Rare Disorders (2000 to 2015). Over recent years he has gradually retired from full-time rare disease advocacy work.

John stepped down from ISMRD’s board in 2019 to deal with a number of family health issues and to be the primary carer for Hollie, who had increasing care needs. Hollie died in July 2021. He has maintained contact with ISMRD through its social media channel and still provides support to families with Mannosidosis when questions arise, and occasional advice to the ISMRD board.

Pam Tobey, Board Emeritus, US

Pam is the mother to Autumn who is a MLIII adult. Pam and her husband, David, live in Arkansas and are parents also to another daughter, Michelle. She is a hairdresser and owner of her own salon.

Pam has conducted several fundraisers in her very small town…from baking and selling giant cookies to having gigantic yard sales. She is extremely passionate about finding funds for the ISMRD and dreams of the day when research is “rolling” and a cure found for Glycoprotein Storage Diseases.

Jenny Noble, Board Emeritus, New Zealand

Jenny Noble is the parent of two young adults with Mucolipidosis Type III (Pseudo-Hurler Polydystrophy).

Since the diagnosis of her two children Jenny has spent many years searching and advocating for innovative ways to manage the complications of Mucolipidosis. Through this advocacy Jenny has built up strong international networks with professionals, families, industry and other support groups to improve outcomes for families with Lysosomal Diseases.

Jenny joined the board in 2004 and was an active member until her resignation in November 2020. She now works in an advisory capacity as Board emeritus.

Though not trained in health or science, she is one of the co-authors of The Osteodystrophy of Mucolipidosis Type III and the Effects of Intravenous Pamidronate Treatment published in the Journal of Inherited Metabolic Diseases.